Previous close | 0.4745 |
Open | 0.4769 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.4646 - 0.4898 |
52-week range | 0.3700 - 1.5000 |
Volume | |
Avg. volume | 235,538 |
Market cap | 47.148M |
Beta (5Y monthly) | 0.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.6300 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of
Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.
Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management tea